Detalhe da pesquisa
1.
Targeting transcription regulation in cancer with a covalent CDK7 inhibitor.
Nature
; 511(7511): 616-20, 2014 Jul 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-25043025
2.
Compartment-Specific Bioluminescence Imaging platform for the high-throughput evaluation of antitumor immune function.
Blood
; 119(15): e131-8, 2012 Apr 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-22289890
3.
Methyljasmonate displays in vitro and in vivo activity against multiple myeloma cells.
Br J Haematol
; 159(3): 340-51, 2012 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-22970818
4.
Adenosine A2A receptor agonists and PDE inhibitors: a synergistic multitarget mechanism discovered through systematic combination screening in B-cell malignancies.
Blood
; 116(4): 593-602, 2010 Jul 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-20382846
5.
Inhibition of tumor cells interacting with stromal cells by xanthones isolated from a Costa Rican Penicillium sp.
J Nat Prod
; 75(4): 793-7, 2012 Apr 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-22458669
6.
Molecular and cellular effects of multi-targeted cyclin-dependent kinase inhibition in myeloma: biological and clinical implications.
Br J Haematol
; 152(4): 420-32, 2011 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-21223249
7.
Anti-tumor activity and signaling events triggered by the isothiocyanates, sulforaphane and phenethyl isothiocyanate, in multiple myeloma.
Haematologica
; 96(8): 1170-9, 2011 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-21712538
8.
Activation, immune polarization, and graft-versus-leukemia activity of donor T cells are regulated by specific subsets of donor bone marrow antigen-presenting cells in allogeneic hemopoietic stem cell transplantation.
J Immunol
; 183(12): 7799-809, 2009 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-19933853
9.
Emerging treatments for multiple myeloma: beyond immunomodulatory drugs and bortezomib.
Semin Hematol
; 46(2): 166-75, 2009 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-19389500
10.
In vitro anti-myeloma activity of the Aurora kinase inhibitor VE-465.
Br J Haematol
; 147(5): 672-6, 2009 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-19751238
11.
Stromal-mediated protection of tyrosine kinase inhibitor-treated BCR-ABL-expressing leukemia cells.
Mol Cancer Ther
; 7(5): 1121-9, 2008 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-18445657
12.
Author Correction: Tumor cell-specific bioluminescence platform to identify stroma-induced changes to anticancer drug activity.
Nat Med
; 30(4): 1214, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38355975
13.
Targeting BRAFV600E in thyroid carcinoma: therapeutic implications.
Mol Cancer Ther
; 6(3): 1070-8, 2007 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-17363500
14.
Potentiation of antileukemic therapies by Smac mimetic, LBW242: effects on mutant FLT3-expressing cells.
Mol Cancer Ther
; 6(7): 1951-61, 2007 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-17620426
15.
Bcl-2 overexpression in thyroid carcinoma cells increases sensitivity to Bcl-2 homology 3 domain inhibition.
J Clin Endocrinol Metab
; 92(12): 4845-52, 2007 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-17848408
16.
The proteasome inhibitor bortezomib induces apoptosis in human retinoblastoma cell lines in vitro.
Invest Ophthalmol Vis Sci
; 48(10): 4706-19, 2007 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-17898295
17.
The role of the bone marrow microenvironment in the pathophysiology of myeloma and its significance in the development of more effective therapies.
Hematol Oncol Clin North Am
; 21(6): 1007-34, vii-viii, 2007 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-17996586
18.
Fas signaling in thyroid carcinomas is diverted from apoptosis to proliferation.
Clin Cancer Res
; 12(12): 3705-12, 2006 Jun 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-16778096
19.
Complete regression of large solid tumors using engineered drug-resistant hematopoietic cells and anti-CD137 immunotherapy.
Hum Gene Ther
; 17(8): 798-806, 2006 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-16942440
20.
Antitumor effects of the proteasome inhibitor bortezomib in medullary and anaplastic thyroid carcinoma cells in vitro.
J Clin Endocrinol Metab
; 91(10): 4013-21, 2006 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-16849420